Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2021-04-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no regulatory filings related to financial performance, no management or board changes, no voting results, no earnings or annual report information. The document is an official company announcement about intellectual property rights, which does not fit into any specific financial report category. Given the short length and nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous company announcements that do not fit other categories.
2021-04-13 Chinese
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acceptance of medical device registration applications by a regulatory authority (Jilin Province Drug Administration). It details the products involved, their clinical uses, and the current status of the registration process. The document explicitly states that the acceptance of these registrations will not impact recent performance and that further updates will be disclosed as necessary. The document is short (1231 characters) and serves as a regulatory announcement about product registration status rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-08 Chinese
关于控股股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder. It details the number of shares released from pledge, the shareholder involved, and the status of pledged shares. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification, as it concerns changes in significant share ownership or share pledging status by a major shareholder. The document length is short and focused on shareholding changes, not a full report or regulatory filing. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2021-04-01 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It includes details about the patent number, inventors, application date, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, or voting results. The document is an official company announcement about intellectual property, which does not fit into any specific financial report category. Given the short length and nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous company announcements that do not fit other categories.
2021-04-01 Chinese
关于公司获得医疗器械注册证暨医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt and changes of medical device registration certificates issued by a regulatory authority (Jilin Province Drug Administration). It details specific product registrations and changes, their validity periods, and clinical uses. The document is relatively short (1939 characters) and does not contain financial statements, management discussion, or detailed financial data. It is an official announcement about regulatory approvals and product certifications, not a financial report or management report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a voting result, board change, or capital update. The content is regulatory in nature but specific to product registration certificates. Given the options, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2021-04-01 Chinese
2021年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2021 by the company 迪瑞医疗科技股份有限公司. It provides estimated financial performance figures (net profit growth) and explanations for the changes but explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the official quarterly report later. The document is short (833 characters) and serves as an earnings preview rather than a full interim or quarterly report containing actual financial statements or substantive financial data. Therefore, it fits best as an Earnings Release (ER), which is the initial announcement of quarterly financial results highlights. Q1 2021
2021-03-28 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.